- Home
- NVAX vs OPK Comparison
NVAX vs OPK Comparison
Compare NVAX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- OPK
- Stock Information
- Founded
- NVAX 1987
- OPK 2007
- Country
- NVAX United States
- OPK United States
- Employees
- NVAX N/A
- OPK N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- NVAX Health Care
- OPK Health Care
- Exchange
- NVAX Nasdaq
- OPK Nasdaq
- Market Cap
- NVAX 1.3B
- OPK 1.3B
- IPO Year
- NVAX 1995
- OPK 1995
- Fundamental
- Price
- NVAX $8.17
- OPK $1.72
- Analyst Decision
- NVAX Buy
- OPK Strong Buy
- Analyst Count
- NVAX 6
- OPK 3
- Target Price
- NVAX $17.83
- OPK $2.75
- AVG Volume (30 Days)
- NVAX 4.7M
- OPK 8.3M
- Earning Date
- NVAX 05-09-2025
- OPK 05-06-2025
- Dividend Yield
- NVAX N/A
- OPK N/A
- EPS Growth
- NVAX N/A
- OPK N/A
- EPS
- NVAX N/A
- OPK N/A
- Revenue
- NVAX $682,162,000.00
- OPK $713,142,000.00
- Revenue This Year
- NVAX N/A
- OPK N/A
- Revenue Next Year
- NVAX $15.02
- OPK $6.25
- P/E Ratio
- NVAX N/A
- OPK N/A
- Revenue Growth
- NVAX N/A
- OPK N/A
- 52 Week Low
- NVAX $3.81
- OPK $0.86
- 52 Week High
- NVAX $23.86
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- NVAX 51.30
- OPK 49.72
- Support Level
- NVAX $7.66
- OPK $1.85
- Resistance Level
- NVAX $8.48
- OPK $1.95
- Average True Range (ATR)
- NVAX 0.64
- OPK 0.10
- MACD
- NVAX 0.08
- OPK -0.01
- Stochastic Oscillator
- NVAX 71.43
- OPK 23.81
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.